A multicenter self-comparing study of enteral nutrition powder (AA) combined with mesalazine in the treatment of active Crohn's disease

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000034685

Enrollment

Unknown

Registered

2020-07-14

Start date

2020-07-15

Completion date

Unknown

Last updated

2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's disease

Interventions

experimental group:Enteral nutrition powder (AA)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Aged 18-55 years; 2) diagnosed with Crohn's disease; 3) CDAI score 300-450

Exclusion criteria

Exclusion criteria: 1. Patients with enteral nutrition powder (AA) allergic history or other contraindications. 2. Patients with hemopathy, liver or renal disease. 3. Patients who are misdiagnoised as CD during the study.

Design outcomes

Primary

Measure	Time frame
CDAI<300;NRS2002;	—

Secondary

Measure	Time frame
Mucosal healing;	—

Countries

China

Contacts

Public ContactWang Huahong

wanghan@wanhe-phar.com+86 755 26031131

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026